p16 tumor suppressor gene mutations in Chinese esophageal carcinomas in Hong Kong

Cancer Letters

Volumn 115, Issue 2, 1997, Pages 201-206

  Chan, Wai Chi ^a   Tang, Cecilia Man Ching ^b   Lau, Kwok Wai ^b   Lung, Maria Li ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Esophageal cancer; Mutation; p16 gene

Indexed keywords

ALANINE; THREONINE;

AMINO ACID SUBSTITUTION; ARTICLE; CARCINOGENESIS; CAUCASIAN; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DNA SEQUENCE; ESOPHAGUS CANCER; EXON; HONG KONG; HUMAN; HUMAN TISSUE; JAPAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

AGED; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CHINA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HONG KONG; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 0030897676     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)04748-4     Document Type: Article

References (23)

1. Serrano, M., Hannon, G.J. and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4, Nature (London), 366, 704-707.
2. Kamb, A., Gruis, N., Feldhaus, J., Liu, Q., Harshnman, K., Tavtigian, S., Stockert, E., Day, R., Johnson, B. and Skolnick, M. (1994) A cell cycle regulator potentially involved in genesis of many tumor types, Science (Washington D.C.), 264, 436-439.
3. Liu, Q., Van, Y.X., McClure, M., Nakagawa, H., Fujimura, F. and Rustgi, A.K. (1995) MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines, Oncogene, 10, 619-622.
4. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res., 54, 4855-4878.
5. Lung, M.L., Chan, W.C., Zong, Y.S., Tang, C.M.C., Fok, C.L., Wong, K.T., Chan, L.K. and Lau, K.W. (1996) P53 mutational spectrum of esophageal carcinomas from five different geographical locales in China, Cancer Epidemiol. Biomarkers Prev., 5, 277-284.
6. Pollock, P.M., Pearson, J.V. and Hayward, N.K. (1996) Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions, Genes Chromosomes Cancer, 15, 77-88.
7. Yang, C.S. (1980) Research on esophageal cancer in China: a review. Cancer Res., 40, 2633-2644.
8. Huang, Y., Meltzer, S.J., Yin, J., Tong, Y., Chang, E.H., Srivastava, S., McDaniel, T., Boynton, R.F. and Zou, Z.Q. (1993) Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas, Cancer Res., 53, 1889-1894.
9. Blount, P.L., Meltzer, S.J., Yin, J., Huang, Y., Krasna, M.J. and Reid, B.J. (1993) Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma, Proc. Natl. Acad. Sci. USA, 90, 3221-3225.
10. Hollstein, M., Rice, K., Greenblatt, M.S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorensen, B., Montesano, R. and Harris, C.C. (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res., 22, 3551-3555.
11. Igaki, H., Sasaki, H., Tachimori, Y., Kato, H., Watanabe, H., Kimura, T., Harada, Y., Sugimura, T. and Terada, M. (1995) Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract, Cancer Res., 55, 3421-3423.
12. Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S. and Nakamura, Y. (1994) Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma, Cancer Res., 54, 3396-3397.
13. 1NK4 in human cancer, Proc. Natl. Acad. Sci. USA, 91, 11045-11049.
14. Zhou, X., Tarmin, J.Y., Jiang, H.Y., Suzuki, H., Rhyu, M.G., Abraham, J.M. and Meltzer, S.J. (1994) The MTSI gene is frequently mutated in primary human esophageal tumors, Oncogene, 9, 3737-3741.
15. Esteve, A., Martel-Planche, G., Sylla, B.S., Hollstein, M., Hainaut, P. and Montesano, R. (1996) Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas, Int. J. Cancer, 66, 301-304.
16. De Vos, S., Miller, C.W., Takeuchi, S., Gombart, A.F., Cho, S.K. and Koeffler, H.P. (1995) Alterations of CDKN2 (p16) in non-small cell lung cancer, Genes Chromosomes Cancer, 14, 164-170.
17. Wright, D.K. and Manos, M.M. (1990) Sample preparation from paraffin-embedded tissues. In: M.A. Innis, D.H. Gelfand, J.J. Sninsky and T.S. White (eds.), PCR Protocols: A Guide to Methods and Applications, pp. 153-158. Academic Press, San Diego, CA.
18. Mok, S.C.H., Lo, K.W. and Tsao, S.W. (1993) Direct cycle sequencing of mutated alleles detected by PCR-single-strand conformation polymorphism analysis, Biotechniques, 14, 790-793.
19. Zong, Y.S., Chen, W.S., Cai, S.S. and Qiu, J.W. (1988) Dynamic analysis of the cancer mortality rates during 1970-1987 in Nanao County, Guangdong Province. J, Shantou Univ. (Natural Science Edition, Medical Issue), 3, 1-4.
20. Hong Kong Hospital Authority (1991) Hong Kong Cancer Registry. Hong Kong Hospital Authority, Hong Kong.
21. Zhang, G.S.Y., Klein-Szanto, A.J.P., Sauter, E.R., Shafarenko, M., Mitsunaga, S., Nobori, T., Carson, D.A., Ridge, J.A. and Goodrow, T.L. (1994) Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinomas cell lines than in primary tumors of the head and neck, Cancer Res., 54, 5050-5053.
22. Igaki, H., Sasaki, H., Kishi, T., Sakamoto, H., Tachimori, Y., Kato, H., Watanabe, H., Sugimura, T. and Terada, M. (1994) Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines, Biochem. Biophys. Res. Commun., 203 (2), 1090-1095.
23. Lo, K.W., Huang, D.P. and Lau, K.M. (1995) p16 gene alterations in nasopharyngeal carcinoma, Cancer Res., 55, 2039-2043.